🇺🇸 FDA

Intelligence Platform

Patents

Browse 302 pharma-relevant US patents (A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.

29,054 patents indexed
patent

US 7674923

Process for preparing forms of atorvastatin calcium substantially free of impurities

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7674935

Crystal forms of O-desmethylvenlafaxine

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 09 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Mar 04 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7671071

Polymorphic Form XVI of fexofenadine hydrochloride

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Mar 02 2010 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Feb 25 2030 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7632841

2-N{5-[[4-[2-(methyl-2-pyridinylamino) ethoxy] phenyl]methyl]-2,4-thiazolidinedione} butan

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 15 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 10 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7629458

Preparation of levofloxacin and hemihydrate thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Dec 08 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Dec 03 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7622588

Method for the purification of lansoprazole

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 24 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 19 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7619112

Optical resolution of 3-carbamoylmethyl-5-methyl hexanoic acid

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7618976

Methods for the production of sildenafil base and citrate salt

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7619117

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 17 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Nov 12 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7612203

Rosuvastatin and salts thereof free of rosuvastatin alkylether and a process for the prepa

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7611722

Dosage form with a core tablet of active ingredient sheathed in a compressed annular body

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Nov 03 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 29 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605290

Processes for the synthesis of O-desmethylvenlafaxine

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7605274

Carvedilol

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 20 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 15 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598420

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7598396

Crystalline solids of carvedilol and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Oct 06 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Oct 01 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7582759

Diastereomeric purification of rosuvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Sep 01 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 27 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7579333

Therapy using a combination of raloxifene and alendronate

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 25 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 20 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572834

Rasagiline formulations and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7572641

Pharmaceutical compositions comprising meloxicam and methods of their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Aug 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Aug 06 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563930

Crystal forms of Cinacalcet HCI and processes for their preparation

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7563918

Solid and crystalline ibandronate sodium and processes for preparation thereof

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jul 21 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jul 16 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547787

Processes for preparing montelukast sodium

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7547806

Tannate salt of rasagiline

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue Jun 16 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon Jun 11 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted patent

US 7538136

Crystalline forms of atorvastatin

TEVA PHARMACEUTICAL INDUSTRIES, LTD. · Granted Tue May 26 2009 00:00:00 GMT+0000 (Coordinated Universal Time) · Expires Mon May 21 2029 00:00:00 GMT+0000 (Coordinated Universal Time)

granted